38087395|t|Lipidomics profiling reveals distinct patterns of plasma sphingolipid alterations in Alzheimer's disease and vascular dementia.
38087395|a|BACKGROUND: Alzheimer's disease (AD) and vascular dementia (VaD) are two of the commonest causes of dementia in the elderly. Of the myriad biomolecules implicated in dementia pathogenesis, sphingolipids have attracted relatively scant research attention despite their known involvement in multiple pathophysiological processes. The potential utility of peripheral sphingolipids as biomarkers in dementia cohorts with high concomitance of cerebrovascular diseases is also unclear. METHODS: Using a lipidomics platform, we performed a case-control study of plasma sphingolipids in a prospectively assessed cohort of 526 participants (non-cognitively impaired, NCI = 93, cognitively impaired = 217, AD = 166, VaD = 50) using a lipidomics platform. RESULTS: Distinct patterns of sphingolipid alterations were found in AD and VaD, namely an upregulation of d18:1 species in AD compared to downregulation of d16:1 species in VaD. In particular, GM3 d18:1/16:0 and GM3 d18:1/24:1 showed the strongest positive associations with AD. Furthermore, evaluation of sphingolipids panels showed specific combinations with higher sensitivity and specificity for classification of AD (Cer d16:1/24:0. Cer d18:1/16:0, GM3 d16:1/22:0, GM3 d18:1/16:0, SM d16:1/22:0, HexCer d18:1/18:0) and VAD (Cer d16:1/24:0, Cer d18:1/16:0, Hex2Cer d16:1/16:0, HexCer d18:1/18:0, SM d16:1/16:0, SM d16:1/20:0, SM d18:2/22:0) compared to NCI. CONCLUSIONS: AD and VaD are associated with distinct changes of plasma sphingolipids, warranting further studies into underlying pathophysiological mechanisms and assessments of their potential utility as dementia biomarkers and therapeutic targets.
38087395	57	69	sphingolipid	Chemical	MESH:D013107
38087395	85	104	Alzheimer's disease	Disease	MESH:D000544
38087395	109	126	vascular dementia	Disease	MESH:D015140
38087395	140	159	Alzheimer's disease	Disease	MESH:D000544
38087395	161	163	AD	Disease	MESH:D000544
38087395	169	186	vascular dementia	Disease	MESH:D015140
38087395	188	191	VaD	Disease	MESH:D015140
38087395	228	236	dementia	Disease	MESH:D003704
38087395	294	302	dementia	Disease	MESH:D003704
38087395	317	330	sphingolipids	Chemical	MESH:D013107
38087395	492	505	sphingolipids	Chemical	MESH:D013107
38087395	523	531	dementia	Disease	MESH:D003704
38087395	566	590	cerebrovascular diseases	Disease	MESH:D002561
38087395	690	703	sphingolipids	Chemical	MESH:D013107
38087395	786	789	NCI	Disease	
38087395	824	826	AD	Disease	MESH:D000544
38087395	834	837	VaD	Disease	MESH:D015140
38087395	903	915	sphingolipid	Chemical	MESH:D013107
38087395	942	944	AD	Disease	MESH:D000544
38087395	949	952	VaD	Disease	MESH:D015140
38087395	997	999	AD	Disease	MESH:D000544
38087395	1047	1051	VaD.	Disease	MESH:D015140
38087395	1149	1151	AD	Disease	MESH:D000544
38087395	1180	1193	sphingolipids	Chemical	MESH:D013107
38087395	1292	1294	AD	Disease	MESH:D000544
38087395	1296	1299	Cer	Chemical	-
38087395	1312	1315	Cer	Chemical	-
38087395	1328	1331	GM3	Chemical	-
38087395	1344	1347	GM3	Chemical	-
38087395	1360	1362	SM	Chemical	MESH:D012493
38087395	1375	1381	HexCer	Chemical	-
38087395	1398	1401	VAD	Chemical	-
38087395	1403	1406	Cer	Chemical	-
38087395	1419	1422	Cer	Chemical	-
38087395	1435	1448	Hex2Cer d16:1	Chemical	-
38087395	1455	1461	HexCer	Chemical	-
38087395	1474	1476	SM	Chemical	MESH:D012493
38087395	1489	1491	SM	Chemical	MESH:D012493
38087395	1504	1506	SM	Chemical	MESH:D012493
38087395	1531	1534	NCI	Disease	
38087395	1549	1551	AD	Disease	MESH:D000544
38087395	1556	1559	VaD	Disease	MESH:D015140
38087395	1607	1620	sphingolipids	Chemical	MESH:D013107
38087395	1741	1749	dementia	Disease	MESH:D003704
38087395	Association	MESH:D013107	MESH:D002561
38087395	Association	MESH:D013107	MESH:D000544
38087395	Association	MESH:D013107	MESH:D015140
38087395	Positive_Correlation	MESH:D012493	MESH:D000544

